Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/282780 
Erscheinungsjahr: 
2023
Schriftenreihe/Nr.: 
IZA Discussion Papers No. 16653
Verlag: 
Institute of Labor Economics (IZA), Bonn
Zusammenfassung: 
After the introduction of abuse-deterrent OxyContin in 2010, states with widespread extramedical OxyContin use experienced steep increases in heroin deaths, implying substitution from OxyContin to heroin. Leveraging cross-state variation in initial OxyContin utilization, we show the OxyContin reformulation also induced substitution to a similar prescription opioid product, Opana ER. States with high Opana ER utilization after the OxyContin reformulation experienced continued growth in prescription opioid deaths, and after Opana ER was reformulated 18 months later, an additional wave of substitution to heroin previously solely attributed to OxyContin. Our results highlight underappreciated substitution pathways throughout these pivotal years of the epidemic.
Schlagwörter: 
opioids
opioid epidemic
OxyContin
Opana ER
heroin
JEL: 
I12
I18
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
3.69 MB





Publikationen in EconStor sind urheberrechtlich geschützt.